Definitive Contract 75A50123C00063
Award Date
9/22/23
Potential Completion Date
1/30/26
Potential Value
$749K
Awardee
Gen1E Lifesciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94306, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
100
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...
This is a $222,126,308 cost-plus-incentive federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The contract is for a randomized, double-blind, placebo-controlled, multicenter Phase 2 clinical trial in the U.S. to evaluate the safety and efficacy of novel host-directed therapeutic candidates in hospitalized adults with...
<p>This is a $399,990.96 firm fixed price contract awarded to Alamgir Research Inc. (Ariscience) by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract is for R&D on countering opioid respiratory depression using AI-based drug repositioning and in-vitro validation. The work is under AOI #15 REDIRECT and has an ultimate completion date of April 30, 2025. There is no set-aside designation for this award.</p>
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This is a $557,524.95 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Raisonance Inc. for research and development related to the development of an AI/ML platform using forced cough vocalization to diagnose respiratory infections. The contract has an ultimate completion date of August 31, 2024, and was not set aside for any specific business type. The contract is for work under Announcement of...
<p>This is a $747,499.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Bugseq Inc., a for-profit foreign-owned company, to provide development and clinical validation from metagenomics data using AI and machine learning techniques. The contract has an ultimate completion date of July 23, 2025 and was awarded on June 21, 2024. The contract does not have a set-aside designation.</p>
This is a federal contract award to Regeneron Pharmaceuticals Inc., a for-profit manufacturer of pharmaceuticals and therapeutics. The $692,086,314.00 award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is for the development and production of "novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens" under an Other...
This federal contract award is an Other Transaction Agreement between Global Life Sciences Solutions USA LLC and the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. The $72,104,359.91 cost-sharing agreement is focused on expanding capacity for COVID-19 response and supporting public health emergencies, with a completion date of December 31, 2038. Global Life Sciences Solutions USA LLC, a for-profit limited liability company and wholly owned subsidiary...
This $55,766,220 federal contract was awarded by the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Enalare Therapeutics Inc., a for-profit pharmaceutical company. The contract aims to advance Enalare's "agnostic respiratory stimulant" as a medical countermeasure to treat respiratory depression. This contract is part of a larger Broad Agency Announcement (BAA) from ASPR's Biomedical Advanced Research and...
This is a $719,000.00 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response to The Charles Stark Draper Laboratory, Inc. to develop a high-throughput and immune-competent lung-on-chip with integrated sensing for SARS-CoV-2 analysis. The contract is not set aside for any specific business type. Draper is a not-for-profit research and development organization with expertise in areas such as guidance, navigation, control systems, sensors,...